ProPhase, LLC

February 06, 2014 09:00 ET

ProPhase LLC Hires Michael H. Allen, MD as Vice President of Medical Education

Fast Growing Specialty Service Organization Strengthens Core Competency

NEW YORK, NY--(Marketwired - Feb 6, 2014) - ProPhase announced today that Michael H. Allen, MD has joined the company to lead medical education activities. Dr. Allen comes with deep clinical experience, a distinguished academic career, and leadership roles in several associations aimed at improving treatment paradigms for psychiatry patients.

Dr. Allen joins as vice president of medical education to continue ProPhase's recent successes in delivering highly customized solutions that support clinical trials in over 60 countries, in all phases, across 18 primary indications. He comments, "ProPhase combines the depth of an academic setting with the vitality of the business world."

"We're thrilled about the arrival of Dr. Allen. He brings significant clinical and industry experience as a recognized leader," said Mark Opler, CEO. "Dr. Allen's expertise in psychopharmacology and clinical research methodology complements and enhances the depth of scientific innovation and intellectual capital at ProPhase."

"We're excited to see ProPhase and its community of key opinion leaders worldwide continue to deliver innovative solutions for the issues of applied measurement in clinical trials," said Sofija Jovic, president and COO. "Dr. Allen's arrival will provide us with thought leadership that's vital to our continued success."

Most recently at the University of Colorado, he served as the director of psychiatry for the University Hospital and as professor of psychiatry and emergency medicine. He was instrumental in developing the model Comprehensive Psychiatric Emergency Program at NYU, was a principal investigator in the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder and co-investigator on the NIH Emergency Department Safety and Follow-up Evaluation study (ED SAFE). Working with organizations that provide specialty clinical services, and technologies, he developed and validated the Clinical Global Impression Scale for Schizoaffective Disorder. Dr. Allen's accomplishments have resulted in numerous accolades, including the NARSAD Independent Investigator award and recognition as a Distinguished Fellow of the American Psychiatric Association. He has an esteemed resume regarding leadership roles in several key psychiatric associations and as an editor and author.

About ProPhase LLC
Prophase is a specialty services organization focusing on applied measurement in CNS (psychiatry, neurology, sleep and pain disorders, and rare/orphan diseases). ProPhase's services support all measurement-related activities in clinical trials and their industry experience is unparalleled. For more information visit

Contact Information

  • Contact
    ProPhase, LLC:
    Cambron Henderson
    Director of Operations
    Email Contact